Join Rob Ririe from Pharosity Consulting as he and representatives from Greenwich Biosciences discuss the challenges and opportunities of launching a first of its kind specialty product. The session, titled Ready for Takeoff: Supporting Your Launch Strategy – Operations, Analytics and Performance is scheduled for Thursday, May 2 @ 9:00 AM.
Ready for Takeoff: Supporting Your Launch Strategy – Operations, Analytics and Performance
Launching a specialty product, whether it’s a company first or an addition to the portfolio, is complex. Manufacturers hone their strategies to support the patient journey, drive positive outcomes and a positive return. And because specialty products are unique from traditional therapies, many fail to adequately prepare their operations to fully support the product and provide visibility to its performance across all channels. Join Pharosity Consulting and Greenwich Biosciences for a discussion on the impact of Market Access strategies on operations, what is needed to gain visibility to contracting and pricing activities, how to measure performance, and where these elements fit into your launch plan.